DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
|You are receiving this because you have an account on www.oneGRAVESvoice.com|
|To unsubscribe from these emails, click here|
Trusted Resources: News & Meetings
Latest announcements and gatherings
An interesting read, although the headline is misleading – this study looked at women who have positive TPO antibodies, but who are *euthyroid*. Euthyroid women with thyroid antibody positivity prescribed levothyroxine before and during pregnancy were no more likely to experience a live birth at 34 weeks of gestation than similar women assigned to placebo treatment, according to findings presented at the Endocrine Society Annual Meeting.
“For women who are positive for thyroid antibodies but have a normal thyroid function, giving them levothyroxine started before pregnancy and continued throughout pregnancy does not increase their chances of having a live baby,” Rima Dhillon-Smith, PhD, MRCOG, MBChB, a specialist registrar in obstetrics and gynecology and academic clinical lecturer in early pregnancy and reproductive medicine at the University of Birmingham, United Kingdom, told Endocrine Today. “Levothyroxine should not be provided to women with thyroid antibodies who have a normal thyroid function and are trying for a pregnancy because it has no proven benefit.”
Evidence & EducationQuality of Life, Clinical Outcomes and Safety of Early Prophylactic Levothyroxine Administration in Patients With Gr...Objective: While radioiodine therapy is...
Evidence & EducationFollow-Up and Evaluation of the Pregnancy Outcome in Women of Reproductive Age With Graves’ Disease After 131 ...The aims of the present study were to an...
Evidence & EducationThyroid Hormone Therapy and InfertilityThyroid hormone plays a major role in bo...
Evidence & EducationPrevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves’ Disease By Early Initiatio...Background: Radioactive iodine (RAI) th...
Evidence & EducationManagement of Neonates Born to Women With Graves’ Disease: A Cohort StudyObjective: Hyperthyroidism in neonates ...
Evidence & EducationA 6-Year Follow-Up of a Randomized Prospective Trial Comparing Methimazole Treatment With or Without Exogenous L-Thy...Objective: Antithyroid drug therapy is ...
Community CenterThe History of Levothyroxine – The Most Prescribed Drug in the United States With Dr. James V. Hennessey from Harv...In this interview, Dr. Hennessey describ...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.